Last update:

Immunology news

Oncology & Cancer

A battle of rafts: How molecular dynamics in CAR T cells explain their cancer-killing behavior

A study published in Science Advances shares new insights into how two of the most common types of chimeric antigen receptor (CAR) T cells kill cancer.

Immunology

T cells' capability to fully prevent acute viral infections opens new avenues for vaccine development

Scientists from Duke-NUS Medical School and the Singapore General Hospital have discovered that T cells—white blood cells that can destroy harmful pathogens—can completely prevent viral infection, to an extent previously ...

Oncology & Cancer

Study identifies TBK1 as key to overcoming CAR T resistance

Russell W. Jenkins, MD, Ph.D., a physician investigator in the Krantz Family Center for Cancer Research at the Mass General Cancer Center and an assistant professor of Medicine at Harvard Medical School, is senior author ...

Diseases, Conditions, Syndromes

Immune-targeted approach helps control tuberculosis in mice

Mice infected with the bacteria that cause tuberculosis (TB) fared better when treated with an experimental compound that modulates immune responses than untreated mice did, according to a study led by Christina Stallings, ...

Diseases, Conditions, Syndromes

Gene therapy could treat chronic hypereosinophilia

A study published in Human Gene Therapy has involved the generation of a human monoclonal antibody (mAb) directed against human eosinophils. The heavy and light chains of that fully human anti-human eosinophil mAb were delivered ...

Diseases, Conditions, Syndromes

Bile acids' surprising role in food allergy treatment revealed

Metabolites—small molecules within cells, biofluids, tissues or organisms—play an integral role in various diseases, and studying the many metabolites (metabolomics) can teach us how the body works in ways that help researchers ...

Immunology

How a simple amino acid could shape immune response

A study conducted by researchers at the Kennedy Institute of Rheumatology has uncovered a pivotal role of asparagine metabolism in regulating B cell homeostasis and immune response.

Oncology & Cancer

Discovery of CAR-T 'memory cells' could boost cancer therapy

Researchers at the University of Colorado Anschutz Medical Campus have discovered that some CAR-T cells engineered to fight cancer and other conditions carry the memory of past encounters with bacteria, viruses and other ...

Diseases, Conditions, Syndromes

How SARS-CoV-2 defeats the innate immune response

The novel coronavirus SARS-CoV-2 has an enzyme that can counteract a cell's innate defense mechanism against viruses, explaining why it is more infectious than the previous SARS and MERS-causing viruses. A Kobe University ...

Oncology & Cancer

New CAR-T cells offer on-demand control for cancer treatment

Ludwig Cancer Research scientists have devised new types of chimeric antigen-receptor (CAR) T cells—a type of cancer immunotherapy—that can be switched on to varying degrees of intensity and then switched off on demand ...

Immunology

Key receptor reveals how gut cells detect harmful invaders

The human gut is home to helpful microbes, called the microbiota, who produce molecules known as metabolites. These metabolites are being increasingly recognized for their role in supporting our health.

Immunology

Air pollution linked to having a peanut allergy during childhood

Exposure to higher levels of air pollution as a baby is linked to having a peanut allergy throughout childhood, according to a new study. And policies aimed at tackling poor air quality could potentially reduce the prevalence ...

Health

How vitamin D deficiency can lead to autoimmune diseases

As Canadians brace for "vitamin D winter"—months when the sun's angle is too low to produce the vitamin in the skin—a McGill University study explains why vitamin D deficiency early in life is associated with a higher ...

Oncology & Cancer

Biomarker may predict immunotherapy response in liver cancer

It may soon be possible to determine which patients with a type of liver cancer called hepatocellular carcinoma would benefit from immunotherapy, according to a preclinical study by Weill Cornell Medicine investigators.

Oncology & Cancer

Scientists explore new mechanisms to combat glioblastoma

Glioblastoma is the most common and aggressive type of primary brain tumor, with an average survival rate of 15 months, according to the Centers for Disease Control and Prevention. While glioblastoma can be diagnosed at any ...

Immunology

Unique immune response in lupus paves the way for new treatments

Immune cells called monocytes produce a key inflammatory protein called interleukin-1 beta (IL-1β) through an unconventional pathway in patients with systemic lupus erythematosus, commonly referred to as lupus, according ...

Genetics

Uncovering a way for pro-B cells to change trajectory

Development of B cells, white blood cells that make antibodies, follows a progression of stages: common lymphoid progenitors, pre-pro-B cells, pro-B cells, pre-B cells, immature B cells, and then more mature and specialized ...